#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma recurrent Vascular malformation Angelman's syndrome Synovial sarcoma metastatic Frontotemporal dementia Alport's syndrome Diabetes insipidus Progressive familial intrahepatic cholestasis Erythema Hormone-dependent prostate cancer Acute respiratory distress syndrome Ischaemic stroke Hyperinsulinism Waldenstrom's macroglobulinaemia recurrent Immune-mediated enterocolitis More trials…

    Learn about Rare Diseases

    Crigler-Najjar syndrome – Treatment Glycogen storage disease type II – Life with Disease Haemophagocytic lymphohistiocytosis Osteosarcoma – Life with Disease Adrenogenital syndrome – Treatment Hairy cell leukaemia – Treatment Wolfram syndrome Synovial sarcoma recurrent – Treatment Sarcoma – Life with Disease Biotinidase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ribonucleic Acid K30 Nystatin Diclofenac Zanubrutinib Mps-106 Nitrogen ANXV Repotrectinib Lactose Sapropterin Dihydrochloride Gskvx000000008885 Anthoxanthum Odoratum Povidone Hu5F9‐G4 Magnesium Oxide, Light Diltiazem Hydrochloride GVV858 [18F] CANAGLIFLOZIN Folinic Acid Bempikibart More therapies…

    Learn about Your Condition

    Cardiogenic shock Urinary incontinence Noninfective chorioretinitis Solitary fibrous tumour Lymphangioleiomyomatosis Primary myelofibrosis Post procedural infection Hypertriglyceridaemia Tachypnoea Angiosarcoma recurrent Lung disorder Coronary artery dissection Herpes simplex meningitis Procedural headache Tumour of ampulla of Vater More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Certolizumab Pegol
    • Leflunomide
    • Methotrexate Disodium
    The Netherlands

  • Accelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Acetate
    • Bortezomib
    • Daratumumab
    Germany

  • Long‑term immunity after a 6‑month‑old MMR vaccine (live attenuated) in infants: follow‑up of antibody levels 1‑3 years after routine vaccination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Measles
    • Mumps
    • Rubella
    Investigated Drugs:
    • RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Denmark

  • Study of MK-1045 plus rituximab in patients with newly diagnosed follicular lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Vinorelbine
    • Bendamustine Hydrochloride
    • Betamethasone Sodium Phosphate
    France Greece Spain

  • A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

    Recruiting

    2 1
    The Netherlands Poland

  • Phase Ib/II Study of Bexmarilimab Plus Doxorubicin in Adults with Metastatic Soft Tissue Sarcoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Bexmarilimab
    • Doxorubicin Hydrochloride
    Spain
Previous Page
1 … 5 6 7 8 9 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!